Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiar...
Read more
Bologna, Italy – November 8, 2023 — Alfasigma S.p.A. (“Alfasigma”) announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. (“Interstellar”), successf...
Read more
Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company headquartered in Italy, announced today that it has signed a letter of intent to acquire the Jyseleca® business from Galapagos (Euronex...
Read more
Bologna, Italy– October 11, 2023 — Alfasigma S.p.A. (“Alfasigma”) today announced that its wholly-owned subsidiary, Interstellar Acquisition Inc., a Delaware corporation (“Purchaser”), has...
Read more
Bologna, Italia e Morristown, New Jersey, Stati Uniti d’America – 26 settembre 2023 - Alfasigma S.p.A (“Alfasigma”), one of Italy's leading pharmaceutical companies, and Intercept Pharmaceutic...
Read more
CARE&GO is Alfasigma's innovative summer social campaign, which will accompany travelers during the summer period, giving advice easy to put into practice everyday....
Read more
Connecting the Dots was the main topic of the third Global Leadership Meeting held in Barcelona on 28th – 30th of June. An important milestone in the company’s journey to outline and reach its ful...
Read more
On December 14th, the second edition of our Global Leadership Team (GLM) was held in Rome...
Read more
About 15 million euros invested, more than 1,050 square meters, 30 percent of spaces upgraded. Ribbon cutting took place in the presence of Governor Marsilio ...
Read more
The acquisition process, already announced last August, was completed on schedule and marks the beginning of the integration process of the two companies. Alfasigma steadies its leadership in the gas...
Read moreYou’re entering Alfasigma global website
I agree